Shell Asset Management’s Coherus Oncology CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $7K | Sell |
|
|||||
|
2025
Q1 | $14K | Sell |
|
|||||
|
2024
Q4 | $24K | Hold |
|
|||||
|
2024
Q3 | $18K | Buy |
|
|||||
|
2024
Q1 | $26K | Sell |
|
|||||
|
2023
Q4 | $54K | Sell |
|
|||||
|
2023
Q3 | $78K | Sell |
|
|||||
|
2023
Q2 | $91K | Sell |
|
|||||
|
2023
Q1 | $146K | Sell |
|
|||||
|
2022
Q4 | $170K | Sell |
|
|||||
|
2022
Q3 | $248K | Sell |
|
|||||
|
2022
Q2 | $236K | Buy |
|
|||||
|
2022
Q1 | $420K | Sell |
|
|||||
|
2021
Q4 | $595K | Buy |
|
|||||
|
2021
Q3 | $597K | Sell |
|
|||||
|
2021
Q2 | $536K | Buy |
|
|||||
|
2021
Q1 | $535K | Buy |
|
|||||
|
2020
Q4 | $309K | Buy |
|